FIELD: pharmacology.
SUBSTANCE: invention relates to a new naproxen derivative of the formula (I)
,
3-((S)-2-(6-methoxynaphth-2-yl)propanoyloxy)-4.5-bis(((S)-2-(6-methoxynaphth-2-yl)propanoyloxy)methyl)-2-methylpyridinium(S)-2-(6-methoxynaphth-2-yl)propanoate.
EFFECT: high anti-inflammatory, analgesic and antipyretic activity, low acute toxicity and gastrotoxicity.
7 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NON-STEROID ANTI-INFLAMMATORY AGENTS BASED ON PYRIDOXINE DERIVATIVES | 2012 |
|
RU2513089C1 |
| WATER-SOLUBLE SALAMIDE DERIVATIVE POSSESSING TRANQUILISING, NOOTROPIC AND ANALGESIC ACTIVITY | 2012 |
|
RU2540464C2 |
| ANTI-INFLAMMATORY PREPARATION BASED ON KETOPROFEN AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2694221C1 |
| PHARMACEUTICAL COMPOSITIONS BASED ON INDOMETHACIN MENTHYL ETHER AND THEIR APPLICATION AS ANTI-INFLAMMATORY AGENTS | 2017 |
|
RU2685257C1 |
| 5-ETHYL-2-AMINO-1,3,4-THIADIAZOLE DERIVATIVES WITH ANESTHETIC, ANTI-INFLAMMATORY, ANTI-ALLERGIC AND ANALGETIC ACTIVITY | 2016 |
|
RU2651572C2 |
| METHOD OF ENHANCING PROLONGED FEBRIFUGAL ACTION AND REDUCTION OF TOXICITY OF SALICYLATES | 2008 |
|
RU2382763C2 |
| GEL FORM OF NIMESULIDE POSSESSING ANTI-INFLAMMATORY AND ANALGESIC ACTION | 2015 |
|
RU2593777C1 |
| 4,10-DI(ETOXYACETIL)-2,6,8,12-TETRAACETIL-2,4,6,8,10,12-HEXAAZATETRACYCLO [5,5,0,0,0]DODECANE AS ANTI-INFLAMMATORY | 2022 |
|
RU2798994C1 |
| ANALGETIC, ANTIPYRETIC AND ANTI-INFLAMMATORY AGENT "PENTABUFEN" | 2002 |
|
RU2222322C1 |
| PHARMACEUTICAL COMPOSITIONS OF THIOCHROMENOL BASED ON A HEXAHYDRO-HETEROCYCLIC COMPOUND WITH ANALGESIC EFFECT, AND METHODS FOR THEIR USE IN DOMESTIC AND FARM ANIMALS | 2022 |
|
RU2812294C2 |
